Vivek Ramaswamy Net Worth

Vivek Ramaswamy, a prominent figure in the biotech and pharmaceutical industries has made a wave in the entrepreneur world. The entrepreneur is considered one of the youngest billionaires in America but recently caught the attention of international media with his foray into politics. Vivek is one of the top candidates for the Republican Party Presidential Election 2024.

As the founder and CEO of Roviant Sciences, he has earned a jaw-dropping net worth of $950 million. The biotech investor's net worth once touched a $1 billion status putting him on the list of the 20 youngest billionaires in the country. Still, due to the market downturn, his net worth came back under the billionaire threshold. Let's delve into the fascinating journey of Vivek Ramaswamy's rise to prominence and discover the factors that are involved behind his staggering net worth figures.

Vivek Ramaswamy 1

Quick Insights Into Vivek Ramaswamy's Personal Life

Full NameVivek Ganapathy Ramaswamy
Age38 years
Birth DayAugust 9, 1985
Birth PlaceCincinnati, Ohio, U.S
SpouseApoorva Ramaswamy
Zodiac SignLEO
Source of WealthBusiness Ventures
ProfessionEntrepreneur & Politician
Net Worth$950 million

Vivek Ramaswamy's Childhood, Early Life & Career Beginnings

The Indian American entrepreneur and the candidate for the Republican Presidential nomination, Vivek Ganapathy Ramaswamy was born in Cincinnati, Ohio on August 9, 1985. The Cincinnati native was born to Hindu Tamil parents who moved from Kerala to Ohio. His father Vivek Ganapathy was an electrical engineer and his mother Geeta Ramaswamy was a psychiatrist.

Vivek Ramaswamy went to Jesuit School St. Xavier High School. Aside from topping the class, he was also commendable in tennis. In 2007, he went to Harvard College where he graduated with a biology degree. He also became the Harvard Political Union president which developed his interest in politics. He received the Bowdoin Prize for Natural Sciences for his thesis work.

The Paul & Daisy Soros Fellowships for New Americans awarded Vivek Ramaswamy a scholarship to assist him in pursuing a Juris Doctor degree at Yale University. He achieved his degree from Yale Law School in 2013.

Early Career

At the time in Harvard College, Vivek co-founded a private social networking website named Campus Venture Network with Travis May. The company provided resources to students who wanted to become entrepreneurs. Later, in 2009, the company was sold to the Ewing Marion Kauffman Foundation.

Moreover, from 2007-2014, he worked at QVT Financial as a Hedge Fund Analyst. He was also a partner there and managed the company's biotech portfolio. In these years, Vivek almost amassed $7 million in total compensation. Well, he claimed that by the time he completed his degree from Yale, he was a multimillionaire. Thanks to his astonishing career.

Vivek Ramaswamy 2

Founding The Roivant Sciences & Rise Of Thriving Career

In 2024, after leaving QVT Financial, Vivek Ramaswamy embarked on his entrepreneurial journey by founding Roivant. It is basically a pharmaceutical company aimed at developing and delivering medicines efficiently and faster. He formed the company to revolutionize the drug development.

Roviant often acquires pharmaceutical drugs that have stagnated in development due to several reasons. The company buys these medicines for pennies on the dollar and then invests more money to aid complete development with the hope of receiving FDA approval. In 2017, the company raised an investment round of $1.1 billion from SoftBank.

In 2020, Roivant sold its five drugs to a Japanese pharmaceutical company Sumitomo Dainippon for $3 billion. Moreover, Ramaswamy took Roivant public through a SPAC merger with a blank-check firm that brought the company value to $7.3 billion in 2021. In the same, Vivek stepped down as the CEO of the company.

Axovant Sciences

In 2015, Axovant Sciences, a Roivant subsidiary company, acquired $362 million in the largest biotech Initial Public Offering (IPO) to date. The company's principal asset was an Alzheimer's medicine named Intepridine, which it obtained from GlaxoSmithKline for $5 million.

However, unfortunately, the drug was not helping the Alzheimer's patient and did not bring any improvement. Before this news went public, the Axovant market cap was $2.5 billion which dropped to $500 million. The Axovant stock plummeted 70% from an all-time high of $2.5 billion. Further, between 2017 and 2020, the company's market cap crashed from $500 million to $20 million, causing the company to shut down.

Transition To Politics: Presidential Race

The entrepreneur turned-politician has a keen interest in politics and his recent move to stand in the US Presidential Elections made so much noise. Ramaswamy had considered standing in the Ohio US Senate election in 2022 but eventually decided against it. In 2203, he formally announced his vision to run for Republican presidential candidate for the upcoming elections. In April, he launched his presidential campaign for the white house which he at first wanted to challenge President Joe Biden in the Democratic primary. However, later he claimed that he would run as an independent candidate.

The Biotech investor announced his decision on the Tucker Carlson Tonight show. Moreover, Politico stated that "Vivek wants to enter the presidential race with an entrepreneurial spirit, unorthodox ideas, and few expectations, which will end up forming a major following that will carry him to the presidency." According to Forbes, he is the second-wealthiest Republican Presidential candidate, behind only Donald Trump.

Vivek Ramaswamy 3

Vivek Ramaswamy's Net Worth In 2024

As of current estimation, Vivek Ramaswamy, the famous biotech owner and "anti-woke" writer has a net worth of $950 million which once reached to 1 billion dollar threshold. His million-dollar empire is tied to his biotech firm, Roivant, and his other strategic investments.

Roviant Sciences Shares

A substantial portion of Vivek Ramaswamy's net worth comes from his 7% stake in his biotechnology firm, Roivant Sciences. As mentioned above, the company sold its five drugs to a Japanese Pharmaceutical company for $3 billion. Now, the company owns 5% of the Roivant. The acquisition of the company's 5% stake made Vivek to earned $176 million in 2020.

According to some public statements, Vivek gleaned $260 million between 2014 and 2020 in total compensation, bonuses, and capital gain. The figures contributed significantly to his overall net worth. Moreover, the company went public through a SPAC merger in 2021. At the time of the merger, the company's market cap was $7.3 billion and Vivek's 8% stake was worth $511 million.

Later, when he was the nominee of the Republican Presidential Primary, the Roviant market cap increased to $8.56 billion, making his stake worth $600 million. Interestingly, there is quite a contradiction in his billionaire status. Forbes estimated that his net worth once reached that status two weeks after his first republican debate but according to Celebrity Net Worth his net worth was never been high enough to make him a billionaire.

Other Significant Ventures

In 2020, Ramaswamy founded a Medicare navigation platform, Chapter Medicare. The next year, he stepped down as the CEO of Roivant and co-founded the Ohio-based company Strive Asset Management. He served as the company executive chairman which was financially supported by top investors like J.D.Vance, and Pete Theil, and venture capitalist organizations like BlackRock.

In early 2023 during Ramaswamy's campaign, Strive Asset Management's market cap surged to above $500 million. Later, in 2023, the company was valued at $300 million. Vivek holds ⅓ of the Strive Asset Management, making his stale worth $100 million.

Books & Appearances

Aside from political endovenous and business ventures, he also wrote books and appeared in many talk shows. He wrote the book "Woke, Inc: Inside Corporate America Social Justice Scam" in 2021 which gained the 2 position on "The New York Times" Best Sellers list in the Hardcover Non-fiction section. Ramaswamy also made appearances in many talk shows including Wake Up America, Spicer & Co., Fox and Freind Lists, Real Time with Bill Maher, Fox Business Tonight, and recently Tucker Carlson Tonight Show.

Real Estate

The millionaire lives in an 11,300-square-foot feet mansion with his wife Apoorva in Columbus, Ohio. He spent $2 million on this mansion in 2021. The home is spread over a 1.2-acre land. Vivek bought this home from Wesley C. Bates, the son of John Bates, who owns the Stanley Steamer. The worth of this home is around $500,000.

Vivek Ramaswamy 4

The Future Of Vivek Ramaswamy's Net Worth

The future of Vivek Ramaswamy's net worth highly depends on the progress of his current business ventures. Well, it is difficult to speculate on the future trajectory of his net worth as it involves different factors. However, let's discuss some of the potential outlooks.

Continued Growth & Sucess Of Roivant Sciences

Seemingly, Vivek Ramaswamy's net worth is closely tied to the growth and performance of the biotech company, Roivant Sciences. As Roivant Sciences reaches the horizon of success and his other ventures in the pharmaceutical sectors, his net worth will continue to increase with the possibility of reaching billionaire status once again.

Expansion Into New Ventures

As a keen entrepreneur and thirst for change, Vivek Ramaswamy may explore other industries to expand his business portfolio. He may explore new opportunities in healthcare, the technological sector, or Artificial intelligence that align with his goals and ideas. Whether through launching a new business, acquiring existing companies, or expanding his current ventures, Vivek's ability to identify and maximize current trends could contribute to growing his net worth.

Political Career

Apart from his venture success and entrepreneurial career, his recent transition into politics tells a lot about his future outlook. In the 2024 US Presidential Election, Ramaswamy came in second place which is causing some speculations that he might elect for a presidential run in the coming election. It is evident that Vivek continues his foray into politics which significantly enhances his net worth trajectory. Moreover, coming into politics increased his brand reputation which is also benefiting his overall wealth.

Frequently Asked Questions

How Did Vivek Ramaswamy Get So Rich?

Vivek Ramaswamy's net worth is majorly linked to his biotech drug development firm Roivant Sciences. Moreover, he also invested in other ventures which contributed to making him rich.

How Much Did Vivek Sell Roviant For?

Vivek Ramaswamy sold around $33 million worth of shares in his drug development company Roviant Sciences. According to a regulatory filing, the Republican presidential candidate sold 3 million for $11.05.

Who Is Vivek Ramaswamy Married To?

Vivek Ramaswamy got married to Aproova T Ramaswamy in 2015. She was a physician by profession. They met at Yale Law School and have two sons together.


Vivek Ramaswamy, a name that garnered the spotlight because of his recent move to run for the race of presidential election is already a millionaire and tech tycoon. The entrepreneur-turned-politician has amassed a net worth of $950 million which he gained mainly from his biotech drug development company, Roivant Sciences. The company went public in 2021.

In 2023, the company stock surged to 40% which increased the worth of Ramaswamy's stake to almost $600 million. Additionally, his strategic investments added significantly to his considerable wealth and influence. He was also the second wealthiest person competing for the US presidential election behind Donald Trump. Whether through his continued leadership, potential foray into politics, or other endeavors, Ramaswamy's net worth is a testament to his business acumen and influence in various industries.

Emma James

A distinguished writer with an impressive 8-year track record of contributing to various prominent informational websites.

Did this article help you?


We love success stories. If you have a minute more, can you share a sentence or two about how this article helped you?

We're sorry. :(

What went wrong?

Thanks for your help!

What do you wish we'd covered in this article?

We're glad you found this helpful.

We're sorry this article wasn’t helpful.